BMA follows Lancet in quitting group on collaboration between doctors and drug industryBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f1574 (Published 08 March 2013) Cite this as: BMJ 2013;346:f1574
- Zosia Kmietowicz
The BMA has become the second organisation in a month to withdraw its support for a document outlining how healthcare professionals and the drug industry could collaborate.
In February, the Lancet said that it no longer backed the four page document,1 which was published in 2012 by the Ethical Standards in Health and Life Sciences Group (ESHLSG). The group is co-chaired by the president of the Royal College of Physicians, Richard Thompson, and the president of the Association of the British Pharmaceutical Industry, Deepak Khanna.2
Richard Horton, editor of the Lancet, said that the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial